Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.45 |
| ▸ | CA3 | P07451 | 2/20 | 0.44 |
| ▸ | CA5A | P35218 | 2/20 | 0.44 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA4 | P22748 | 1/20 | 0.44 |
| ▸ | CA6 | P23280 | 1/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | NQO2 | P16083 | 3/20 | 0.34 |
| ▸ | MTNR1A | P48039 | 3/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2100045 | 1.00 | MEN1 (0.51) | MEN1KMT2ASMN1; SMN2ALDH1A1POLB | |
| SCHEMBL7699524 | 0.94 | SMN1; SMN2 (0.47) | MEN1KMT2ASMN1; SMN2ALDH1A1POLB | |
| SCHEMBL6129080 | 0.89 | ALDH1A1 (0.42) | MEN1KMT2ASMN1; SMN2ALDH1A1POLB | |
| SCHEMBL5492139 | 0.83 | SMN1; SMN2 (0.38) | MEN1KMT2ASMN1; SMN2ALDH1A1HPGD | |
| SCHEMBL17767812 | 0.83 | SMN1; SMN2 (0.50) | SMN1; SMN2ALDH1A1HPGDHTTHDAC8 | |
| SCHEMBL17767809 | 0.83 | SMN1; SMN2 (0.50) | SMN1; SMN2ALDH1A1HPGDHTTHDAC8 | |
| SCHEMBL26382038 | 0.83 | SMN1; SMN2 (0.50) | SMN1; SMN2ALDH1A1HPGDHTTHDAC8 | |
| SCHEMBL17168743 | 0.83 | SMN1; SMN2 (0.50) | SMN1; SMN2ALDH1A1HPGDHTTHDAC8 | |
| SCHEMBL20999873 | 0.83 | SMN1; SMN2 (0.50) | SMN1; SMN2ALDH1A1HPGDHTTHDAC8 | |
| SCHEMBL2615833 | 0.82 | ADRA1A (0.47) | KMT2ASMN1; SMN2HPGDHTTNAMPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120296087-A1 | MORPHOLINO-BASED ANTISENSE AGENT | INDIAN ASSOCIATION FOR THE CULTIVATION OF SCIENCE (IN) | 2012-11-22 | — | — | US | claimed |
| US-20260125413-A1 | UNIVERSAL SOLID SUPPORTS AND PHOSPHORAMIDITE BUILDING BLOCKS FOR OLIGONUCLEOTIDE SYNTHESIS | AM CHEMICALS LLC (US) | 2026-05-07 | — | — | US | disclosed |
| EP-4577539-A1 | UNIVERSAL SOLID SUPPORTS AND PHOSPHORAMIDITE BUILDING BLOCKS FOR OLIGONUCLEOTIDE SYNTHESIS | AM Chemicals Llc (US) | 2025-07-02 | — | — | EP | disclosed |
| WO-2024044792-A1 | UNIVERSAL SOLID SUPPORTS AND PHOSPHORAMIDITE BUILDING BLOCKS FOR OLIGONUCLEOTIDE SYNTHESIS | AM CHEMICALS LLC (US) | 2024-02-29 | — | — | WO | disclosed |
| US-20210139976-A1 | NUCLEOTIDE ANALOGUES AND USE THEREOF FOR NUCLEIC ACID SEQUENCING AND ANALYSIS | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2021-05-13 | — | — | US | disclosed |
| US-10808246-B2 | Oligonucleotide-ligand conjugates and process for their preparation | ALNYLAM PHARMACEUTICALS, INC. (US) | 2020-10-20 | — | — | US | disclosed |
| US-10167391-B2 | Azo compound, use thereof and method for preparing same | BIONEER CORPORATION (KR) | 2019-01-01 | — | — | US | disclosed |
| US-9914745-B2 | Morpholino-based antisense agent | INDIAN ASSOCIATION FOR THE CULTIVATION OF SCIENCE (IN) | 2018-03-13 | — | — | US | disclosed |
| US-20170016050-A1 | NOVEL AZO COMPOUND, USE THEREOF AND METHOD FOR PREPARING SAME | BIONEER CORPORATION (KR) | 2017-01-19 | — | — | US | disclosed |
| US-20160376585-A1 | OLIGONUCLEOTIDE-LIGAND CONJUGATES AND PROCESS FOR THEIR PREPARATION | BANK OF AMERICA, N.A. | 2016-12-29 | — | — | US | disclosed |
| US-6878552-B1 | Homogeneous detection and/or determination method for a chemical or physico-chemical interaction | CIS BIO INTERNATIONAL FRENCH JOINT STOCK COMPANY (FR) | 2005-04-12 | — | — | US | disclosed |
| EP-0954606-B1 | NON-NUCLEOTIDE LINKING REAGENTS | BIOGENEX LAB (US) | 2003-10-15 | — | — | EP | disclosed |
| EP-1235851-A2 | REGULATORS OF THE HEDGEHOG PATHWAY, COMPOSITIONS AND USES RELATED THERETO | Johns Hopkins University School of Medicine (US) | 2002-09-04 | — | — | EP | disclosed |
| WO-2001027135-A9 | REGULATORS OF THE HEDGEHOG PATHWAY, COMPOSITIONS AND USES RELATED THERETO | UNIV JOHNS HOPKINS MED (US) | 2002-08-15 | — | — | WO | disclosed |
| US-6340747-B1 | COMPLEXED TO RARE EARTH METAL CRYPTATE LABEL; DETECTION AND ISOLATION OF NUCLEIC ACIDS | CIS BIO INTERNATIONAL (FR) | 2002-01-22 | — | — | US | disclosed |
| WO-2001027135-A2 | REGULATORS OF THE HEDGEHOG PATHWAY, COMPOSITIONS AND USES RELATED THERETO | JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE (US) | 2001-04-19 | — | — | WO | disclosed |
| US-6130323-A | Non-nucleotide linking reagents | BIOGENEX LABORATORIES (US) | 2000-10-10 | — | — | US | disclosed |
| US-5190864-A | Support-leash-enzyme conjugates, small amount of free enzyme releases large amount of bound enzyme | NORTHEASTERN UNIVERSITY (US) | 1993-03-02 | — | — | US | disclosed |
| US-4937188-A | Enzyme activity amplification method for increasing assay sensitivity | NORTHEASTERN UNIVERSITY (US) | 1990-06-26 | — | — | US | disclosed |
| EP-0243797-A2 | Method for amplifying enzyme activity, enzyme conjugates suitable therefor and their preparation | NORTHEASTERN UNIVERSITY (US) | 1987-11-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160376585-A1 | OLIGONUCLEOTIDE-LIGAND CONJUGATES AND PROCESS FOR THEIR PREPARATION | IGF2R, IRS1, INSR | MEN1 2300/4885KMT2A 2534/4885SMN1; SMN2 1128/4885 |
| US-10808246-B2 | Oligonucleotide-ligand conjugates and process for their preparation | RTCB, IGF2BP2, SNRPE | MEN1 2721/4885KMT2A 2695/4885SMN1; SMN2 1621/4885 |
| US-20120296087-A1 | MORPHOLINO-BASED ANTISENSE AGENT | MYOF, OSBP2, SLCO2B1 | MEN1 3525/4885KMT2A 3562/4885SMN1; SMN2 874/4885 |
| US-20260125413-A1 | UNIVERSAL SOLID SUPPORTS AND PHOSPHORAMIDITE BUILDING BLOCKS FOR OLIGONUCLEOTIDE SYNTHESIS | SSU72, NSUN2, POLR2H | MEN1 3172/4885KMT2A 1229/4885SMN1; SMN2 755/4885 |
| US-20210139976-A1 | NUCLEOTIDE ANALOGUES AND USE THEREOF FOR NUCLEIC ACID SEQUENCING AND ANALYSIS | NUDT1, NT5C3B, RNGTT | MEN1 2372/4885KMT2A 1507/4885SMN1; SMN2 1461/4885 |
| US-10167391-B2 | Azo compound, use thereof and method for preparing same | CRY1, CYP51A1, CYP3A4 | MEN1 706/4885KMT2A 583/4885SMN1; SMN2 4826/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.